GENEVA, Oct. 4 -- NOVOCURE GMBH (Neuhofstrasse 21CH-6340 Baar) filed a patent application (PCT/IB2025/000127) for "ALTERNATING ELECTRIC FIELDS IN COMBINATION WITH TEMOZOLOMIDE AND A CHECKPOINT INHIBITOR FOR USE IN TREATING GLIOBLASTOMA" on Mar 25, 2025. With publication no. WO/2025/202715, the details related to the patent application was published on Oct 02, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): TRAN, David D. (Keck School of Medicine of USC1975 Zonal Ave.Los Angeles, CA 90033), CHEN, Dongjiang (212 N. Marguerita Ave.Apt. BAlhambra, CA 91801)
Abstract: The invention relates to te...